Step into spring as a Hope Builder! With the arrival of a season that symbolizes renewal and progress, we at Open Medicine Foundation are inspired by the strength of those living with ME/CFS and Long COVID. This season of new
Today, we unite in solidarity to observe Long COVID Awareness Day. This day holds profound significance for countless individuals worldwide. We stand together in spirit and purpose, recognizing the extensive impact of SARS-CoV-2. This day serves as a beacon in our
I am thrilled to announce that Danielle Meadows, Ph.D., has joined Open Medicine Foundation as our new Vice President of Research Programs & Operations. With her exceptional background and expertise in biomedical engineering, research administration, and project management, Danielle is poised to play
Imagine our collective strength when we unite for a cure. At Open Medicine Foundation (OMF), we are driven to find effective treatments for ME/CFS and Long COVID. Our global collaboration model harnesses the brightest minds to bring relief to you and
Join the Momentum! Finding people with ME/CFS and Long COVID who can participate in studies is one of the biggest barriers to research. You could be the solution! We’re delighted to share that the OMF StudyME Registry has reached a pivotal achievement
Today, we are privileged to bring you the narrative of extraordinary courage, resilience, and strength. At just 14 years old, Charlotte’s life took an unexpected turn with a diagnosis of ME/CFS. Read Charlotte’s story in her own words: “My name
The ME/CFS Research Roadmap webinars, hosted by the National Institute of Health (NIH), have successfully concluded. These virtual events brought together ME/CFS experts to present current research, identify knowledge gaps, and explore future research opportunities for ME/CFS. Open Medicine
We are excited to share a new publication from the research funded by Open Medicine Foundation (OMF). Jonas Bergquist, MD, PhD, OMF Chief Medical Officer and Director of the OMF-supported ME/CFS Collaborative Research Center at Uppsala University, and colleagues, have
As 2024 begins, we at Open Medicine Foundation are thrilled to review a few highlights and the milestones you made possible in 2023. It was a year filled with incredible achievements, groundbreaking research, and community empowerment. Thanks to your unwavering support, we’ve reached new
Open Medicine Foundation is thrilled to share a new publication from Alain Moreau, PhD & colleagues: “Exploring the neurocognitive consequences of post-exertional malaise in myalgic encephalomyelitis.” This study shows the impact of post-exertional malaise (PEM) on the disturbance of cognition
We’re thrilled to bring you the latest insights into ME/CFS research through an exclusive interview led by advocate and caregiver Janet Dafoe, Ph.D. Today, Ron Davis, Ph.D., OMF Scientific Advisory Board Director, sits down to discuss his most recent publication: “Catalytic Antibodies May Contribute to
Open Medicine Foundation (OMF) is proud to share details of a new OMF-funded publication from Christopher Armstrong, Ph.D., and colleagues: “In vitro B cell experiments explore the role of CD24, CD38 and energy metabolism in ME/CFS.” Read now! From the Desk
What are the advantages of giving from your Donor Advised Fund (DAF)?
How do I make a donation through my DAF?
Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.
Still can’t find your fund?
Donate your appreciated stock directly to OMF and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).Gifting of Stock
Broker: Schwab
DTC #: 0164
Account #: 47083887
Account Registered as:
Open Medicine Foundation
29302 Laro Drive
Agoura Hills, CA 91301
Please speak to your personal tax advisor and then email or call OMF at 650-242-8669 to notify us of your donation or with any questions.
